Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TransMedics Group ( (TMDX) ) has provided an announcement.
TransMedics Group, Inc. has appointed Gerardo Hernandez as the new Chief Financial Officer, effective December 2, 2024, succeeding Stephen Gordon. Hernandez brings over 25 years of financial experience across healthcare and consumer sectors, having previously held significant roles at Alnylam Pharmaceuticals and Shire. The company also updated its 2024 financial outlook, projecting substantial revenue growth. This strategic leadership change aims to enhance TransMedics’ operations and expand its market influence in organ transplantation technologies.
See more data about TMDX stock on TipRanks’ Stock Analysis page.